News
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the 11 best debt-free stocks to invest in right now. The company ...
After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead. Shares of Viking ...
Amgen's expanding rare disease and biosimilar portfolios, coupled with growth potential and dividend history make AMGN stock ...
Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.
If you're looking for stocks that can make dramatic movements in a short time frame, the biotechnology space has what you ...
Fujifilm delivered strong FY2025 results, driven by progress on VISION2030 and a diversified business mix. Read why FUJIY ...
Morgan Stanley slightly lowered its price target for Regeneron Pharmaceuticals while maintaining an overweight rating, ...
16d
Zacks Investment Research on MSNIntellia Gains 29.8% in a Month: How Should You Play the Stock?
Intellia Therapeutics NTLA has put up a stellar performance in the past month. Shares of the company have rallied 29.8% compared with the industry’s rise of 0.4%. The stock has also outperformed the ...
Regeneron launches a $200 million matching donation program for Good Days’ Retinal Disease Fund to enhance patient access to medicines.
Regeneron has not disclosed any specific information regarding its anticipated financial performance for the second quarter 2025, which could lead to investor uncertainty and speculation.
Morse Asset Management Inc has significantly increased its stake in Regeneron Pharmaceuticals, boosting its share count by a ...
Buying $100 In REGN: If an investor had bought $100 of REGN stock 20 years ago, it would be worth $5,977.36 today based on a price of $521.83 for REGN at the time of writing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results